SEC Filing Analysis: Perspective Therapeutics, Inc. (CATX)

Executive Summary

• Trading Significance: Low
• Key Takeaway: The Chief Accounting Officer, Jonathan Robert Hunt, purchased 11,000 shares for approximately $22,295, a minor increase in his holdings.
• Market Impact: The transaction is too small to have a meaningful impact on the stock, representing less than 0.02% of the company's market cap and shares outstanding.

Company Information

Field	Value
Company	Perspective Therapeutics, Inc.
Ticker Symbol	CATX
CIK	0000728387
Industry	Pharmaceutical Preparations

Insider Information

Field	Value
Name	Hunt Jonathan Robert
CIK	0001375410
Title/Position	Chief Accounting Officer
Relationship	Officer

Transaction Details

Field	Value
Form Type	4
Transaction Date	2025-11-13
Transaction Code	P (Open market purchase)
Security Type	Common Stock
Shares Involved	11,000
Price Per Share	$2.0268
Total Value	$22,294.80
Shares Owned After	59,800
Ownership Type	Direct

Financial Impact Assessment

Transaction Materiality

Metric	Value
Transaction Value	$22,294.80
% of Market Cap	0.015%
Shares Transacted	11,000
% of Shares Outstanding	0.015%
Post-Transaction Ownership	59,800 shares (0.08% of outstanding)
Materiality Assessment	Low

Impact Evaluation

• Market Cap Context: For a company with a market capitalization of $150 million, this $22k transaction is negligible.
• Ownership Concentration: The insider's total ownership remains very low at 0.08% of shares outstanding, indicating this purchase does not significantly alter their stake or influence.
• Transaction Significance: Based on the extremely low percentages of market cap and shares outstanding, the transaction is considered routine and not significant.

Market Impact Analysis

Stock Impact Prediction

• Direction: Neutral
• Reasoning: The transaction size is too small to signal a strong conviction from the insider or to influence market sentiment.

Volume & Sentiment

• Expected Volume Impact: Negligible. The transaction is unlikely to affect trading volume.
• Sentiment Indicator: Neutral. While an insider buy is technically a positive, the small scale of this purchase provides no meaningful bullish signal.

Additional Context

Transaction Notes

• Special Circumstances: The reported price is a weighted average. The shares were purchased in multiple transactions ranging from $2.0235 to $2.0300.